clinical trial · NCT05482698
The MC2-25 Cream in Subjects wITh CHronic KIdNEy Disease-aSsociated prurituS (ITCHINESS) Trial
Chronic Kidney Disease-associated PruritusMC2-25 creamMC2-25 vehicle
brief summary
The purpose of this study is to access the efficacy and safety of MC2-25 cream and MC2-25 vehicle for treatment of chronic kidney disease associated pruritus (CKD)-aP).
started
Jul 1, 2022
primary completion
Feb 2, 2024
completion
Feb 2, 2024
last updated
Mar 17, 2025
detailed description
In this trial, subjects who fulfil all inclusion and exclusion criteria are enrolled.
Eligible subjects will be randomised in a 2:1 ratio to MC2-25 cream or MC2-25 vehicle, respectively.
The subjects will apply the assigned investigational medicinal product (IMP) twice daily for 12 weeks.
official title
A Parallel-group (2-Arm), Randomized, Double-blind, 12-week Trial to Evaluate the Efficacy and Safety of MC2-25 Cream and MC2-25 Vehicle in Subjects With Chronic Kidney Disease-associated Pruritus (CKD-aP)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol